Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-16-010246
Filing Date
2016-05-23
Accepted
2016-05-23 12:16:02
Documents
4
Effectiveness Date
2016-05-23

Document Format Files

Seq Description Document Type Size
1 S-8 s8_052316.htm S-8 46719
2 EXHIBIT 5.1 exh_51.htm EX-5.1 6073
3 EXHIBIT 10.1 exh_101.htm EX-10.1 137431
4 EXHIBIT 23.1 exh_231.htm EX-23.1 2472
  Complete submission text file 0001171843-16-010246.txt   193732
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-211529 | Film No.: 161668369
SIC: 2836 Biological Products, (No Diagnostic Substances)